USD
+$0.00
(+0.00%
)At Close (As of Sep 5, 2025)
$2.91M
Market Cap
0
P/E Ratio
0
EPS
$12.50
52 Week High
$1.06
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $4.9M |
Total Revenue | $8M |
Cost Of Revenue | $3.2M |
Costof Goods And Services Sold | $3.2M |
Operating Income | -$15M |
Selling General And Administrative | $15M |
Research And Development | $1.6M |
Operating Expenses | $19M |
Investment Income Net | - |
Net Interest Income | -$1.9M |
Interest Income | $133K |
Interest Expense | $531K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $619K |
Income Before Tax | -$8.3M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$8.3M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8.2M |
Ebitda | -$7.6M |
Net Income | -$8.3M |
Field | Value (USD) |
---|---|
Total Assets | $18M |
Total Current Assets | $12M |
Cash And Cash Equivalents At Carrying Value | $4.6M |
Cash And Short Term Investments | $4.6M |
Inventory | $3.7M |
Current Net Receivables | $3.6M |
Total Non Current Assets | $6.1M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $5.5M |
Intangible Assets Excluding Goodwill | $5.5M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $77K |
Other Non Current Assets | - |
Total Liabilities | $23M |
Total Current Liabilities | $22M |
Current Accounts Payable | $7.9M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $353K |
Total Non Current Liabilities | $503K |
Capital Lease Obligations | $356K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $356K |
Other Current Liabilities | $14M |
Other Non Current Liabilities | $500K |
Total Shareholder Equity | -$4.7M |
Treasury Stock | - |
Retained Earnings | -$415M |
Common Stock | $35M |
Common Stock Shares Outstanding | $2.5M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$9.4M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $619K |
Capital Expenditures | $9K |
Change In Receivables | - |
Change In Inventory | $738K |
Profit Loss | - |
Cashflow From Investment | -$9K |
Cashflow From Financing | $8.4M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$8.3M |
Field | Value (USD) |
---|---|
Gross Profit | $4.9M |
Total Revenue | $8M |
Cost Of Revenue | $3.2M |
Costof Goods And Services Sold | $3.2M |
Operating Income | -$15M |
Selling General And Administrative | $15M |
Research And Development | $1.6M |
Operating Expenses | $19M |
Investment Income Net | - |
Net Interest Income | -$1.9M |
Interest Income | $133K |
Interest Expense | $531K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $619K |
Income Before Tax | -$8.3M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$8.3M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8.2M |
Ebitda | -$7.6M |
Net Income | -$8.3M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company is headquartered in Tel Aviv, Israel.